Evidence map›Paper›PMID 42132716›Full record

ArticleJACC. Case reports2026

Malignant Mitral Valve Prolapse With Life-Threatening Ventricular Arrhythmias: A Multidisciplinary Team-Guided Stepwise Management.

Niloufar Javadi, Arshad Jahangir, Patrycja Galazka, Lauren Howard, Prabhjot Hundal, Chaitanya Tumuluri, Asad Ghafoor, M Fuad Jan, Hartzell V Schaff, A Jamil Tajik

Abstract readCase Reports
In one paragraph

Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Niloufar JavadiAurora Cardiovascular and Thoracic Services, Aurora Sinai/Aurora St Luke's Medical Centers, Aurora Health Care, Milwaukee, Wisconsin, USA.
Arshad JahangirAurora Cardiovascular and Thoracic Services, Aurora Sinai/Aurora St Luke's Medical Centers, Aurora Health Care, Milwaukee, Wisconsin, USA.
Patrycja GalazkaAurora Cardiovascular and Thoracic Services, Aurora Sinai/Aurora St Luke's Medical Centers, Aurora Health Care, Milwaukee, Wisconsin, USA.
Lauren HowardAurora Cardiovascular and Thoracic Services, Aurora Sinai/Aurora St Luke's Medical Centers, Aurora Health Care, Milwaukee, Wisconsin, USA.
Prabhjot HundalAurora Cardiovascular and Thoracic Services, Aurora Sinai/Aurora St Luke's Medical Centers, Aurora Health Care, Milwaukee, Wisconsin, USA.
Chaitanya TumuluriAurora Cardiovascular and Thoracic Services, Aurora Sinai/Aurora St Luke's Medical Centers, Aurora Health Care, Milwaukee, Wisconsin, USA.
Asad GhafoorAurora Cardiovascular and Thoracic Services, Aurora Sinai/Aurora St Luke's Medical Centers, Aurora Health Care, Milwaukee, Wisconsin, USA.
M Fuad JanAurora Cardiovascular and Thoracic Services, Aurora Sinai/Aurora St Luke's Medical Centers, Aurora Health Care, Milwaukee, Wisconsin, USA.
Hartzell V SchaffDepartment of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA.
A Jamil TajikAurora Cardiovascular and Thoracic Services, Aurora Sinai/Aurora St Luke's Medical Centers, Aurora Health Care, Milwaukee, Wisconsin, USA. Electronic address: a.jamil.tajik@aah.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

clinical conditionA 45-year-old woman with long-standing bileaflet myxomatous mitral valve prolapse (MVP), mitral annular disjunction, and mild mitral regurgitation (MR) developed near-syncope and was found to have frequent polymorphic ventricular tachycardia on ambulatory monitoring. Despite medical therapy, she experienced recurrent ventricular fibrillation and multiple implantable cardioverter-defibrillator (ICD) shocks. KEY QUESTIONS: Can malignant arrhythmogenic MVP occur in the absence of severe MR or detectable myocardial fibrosis on cardiac magnetic resonance imaging? Which combination of electrical and mechanical risk markers identifies patients at imminent risk for sudden cardiac death? Can early surgical correction of the mechanical substrate durably suppress ventricular arrhythmias? OUTCOME: The patient underwent mitral valve repair. Since then, she has remained free of arrhythmias and ICD shocks. TAKE-HOME MESSAGES: Malignant MVP can manifest with multifocal ventricular tachycardia independent of MR severity. Prophylactic ICD placement followed by definitive mitral valve repair reduces arrhythmic triggers and prevents sudden cardiac death.

Indexed as

Barlow syndromeechocardiographymitral valve prolapseventricular arrhythmia

Identifiers

PMID42132716
PMCPMC13326271

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.